Andreasen Camilla H, Stender-Petersen Kirstine L, Mogensen Mette S, Torekov Signe S, Wegner Lise, Andersen Gitte, Nielsen Arne L, Albrechtsen Anders, Borch-Johnsen Knut, Rasmussen Signe S, Clausen Jesper O, Sandbaek Annelli, Lauritzen Torsten, Hansen Lars, Jørgensen Torben, Pedersen Oluf, Hansen Torben
Steno Diabetes Center, Niels Steensens Vej 1, NLC2.13, DK-2820 Gentofte, Denmark.
Diabetes. 2008 Jan;57(1):95-101. doi: 10.2337/db07-0910. Epub 2007 Oct 17.
Three independent studies have shown that variation in the fat mass and obesity-associated (FTO) gene associates with BMI and obesity. In the present study, the effect of FTO variation on metabolic traits including obesity, type 2 diabetes, and related quantitative phenotypes was examined.
The FTO rs9939609 polymorphism was genotyped in a total of 17,508 Danes from five different study groups.
In studies of 3,856 type 2 diabetic case subjects and 4,861 normal glucose-tolerant control subjects, the minor A-allele of rs9939609 associated with type 2 diabetes (odds ratio 1.13 [95% CI 1.06-1.20], P = 9 x 10(-5)). This association was abolished when adjusting for BMI (1.06 [0.97-1.16], P = 0.2). Among 17,162 middle-aged Danes, the A-allele associated with overweight (1.19 [1.13-1.24], P = 1 x 10(-12)) and obesity (1.27 [1.20-1.34], P = 2 x 10(-16)). Furthermore, obesity-related quantitative traits such as body weight, waist circumference, fat mass, and fasting serum leptin levels were significantly elevated in A-allele carriers. An interaction between the FTO rs9939609 genotype and physical activity (P = 0.007) was found, where physically inactive homozygous risk A-allele carriers had a 1.95 +/- 0.3 kg/m(2) increase in BMI compared with homozygous T-allele carriers.
We validate that variation in FTO is associated with type 2 diabetes when not adjusted for BMI and with an overall increase in body fat mass. Furthermore, low physical activity seems to accentuate the effect of FTO rs9939609 on body fat accumulation.
三项独立研究表明,脂肪量和肥胖相关(FTO)基因的变异与体重指数(BMI)及肥胖有关。在本研究中,我们检测了FTO变异对包括肥胖、2型糖尿病及相关定量表型在内的代谢性状的影响。
对来自五个不同研究组的总共17508名丹麦人进行FTO rs9939609多态性基因分型。
在对3856例2型糖尿病病例受试者和4861例糖耐量正常对照受试者的研究中,rs9939609的次要A等位基因与2型糖尿病相关(比值比1.13[95%可信区间1.06 - 1.20],P = 9×10⁻⁵)。调整BMI后,这种关联消失(1.06[0.97 - 1.16],P = 0.2)。在17162名中年丹麦人中,A等位基因与超重(1.19[1.13 - 1.24],P = 1×10⁻¹²)和肥胖(1.27[1.20 - 1.34],P = 2×10⁻¹⁶)相关。此外,A等位基因携带者的体重、腰围、脂肪量和空腹血清瘦素水平等与肥胖相关的定量性状显著升高。发现FTO rs9939609基因型与体力活动之间存在相互作用(P = 0.007),与纯合T等位基因携带者相比,缺乏体力活动的纯合风险A等位基因携带者的BMI增加了1.95±0.3kg/m²。
我们证实,在未调整BMI时,FTO变异与2型糖尿病相关,且与体脂肪量总体增加有关。此外,低体力活动似乎会加剧FTO rs9939609对体脂肪堆积的影响。